Skip to main content

Lung Diseases Research

CFDA 93.838 · Federal Grants & Funding

Total Funding

$161.3M

Awards

5

Recipients

5

States

5

Last Updated

Feb 9, 2026

Yearly Funding Trend

Yearly federal funding for CFDA program 93.838 (Lung Diseases Research), with obligated amounts, award counts, and year-over-year change.
Fiscal YearObligationsAwardsYoY Change
2024$157.5M4
2025$3.7M1-97.6%

Award Type Mix

CFDA program 93.838 (Lung Diseases Research) federal awards broken down by award type, with obligated amounts and award counts.
TypeObligationsAwards
$00
$00

Top 5 Awards under CFDA 93.838

Largest individual obligations for Lung Diseases Research.

Download CSV
Top 5 Awards under CFDA 93.838
AwardRecipientAwarding AgencyPlaceFYObligation
ASST_NON_OT3HL147154_075
NHLBI DATA STAGE COORDINATING CENTER - NO ABSTRACT PROVIDED
UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
North Carolina
Department of Health and Human Services
National Institutes of Health
CHAPEL HILL, NC-042024$75,569,762
ASST_NON_U01HL123009_075
CCC FOR NHLBI PREVENTION AND EARLY TREATMENT OF ACUTE LUNG INJURY PETAL NETWORK - PROJECT SUMMARY THIS PROPOSAL IS A RESPONSE TO THE RFA-HL-14-015 FOR THE COORDINATING CENTER OF…
THE GENERAL HOSPITAL CORPORATION
Massachusetts
Department of Health and Human Services
National Institutes of Health
MA-902024$64,183,283
ASST_NON_P01HL128192_075
PERSONALIZED SMALL MOLECULE THERAPY FOR SEVERE ASTHMA AND CYSTIC FIBROSIS. - OVERALL ABSTRACT OUR OVERALL GOAL IS TO TRANSLATE NEW, SMALL MOLECULE DRUGS INTO PERSONALIZED THERAPIE…
TRUSTEES OF INDIANA UNIVERSITY
Indiana
Department of Health and Human Services
National Institutes of Health
INDIANAPOLIS, IN-072024$12,234,490
ASST_NON_R01HL121270_075
NOVEL QUANTITATIVE EMPHYSEMA SUBTYPES IN MESA AND SPIROMICS - CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) AND EMPHYSEMA, JOINTLY, ARE THE FOURTH LEADING CAUSE OF DEATH IN THE US…
THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
New York
Department of Health and Human Services
National Institutes of Health
NY-902024$5,550,201
ASST_NON_R01HL128492_075
PREVENTION OF LUNG TRANSPLANT INJURY WITH ADENOSINE 2A RECEPTOR AGONIS -  DESCRIPTION (PROVIDED BY APPLICANT): OUR LABORATORY HAS FOCUSED ON DEVELOPING THERAPIES TO IMPROVE TH…
UNIVERSITY OF MARYLAND, BALTIMORE
Maryland
Department of Health and Human Services
National Institutes of Health
MD-902025$3,738,760

Top 5 awards shown, ranked by obligated amount. Dates reflect performance period; last-modified dates match USAspending.gov. Complete listings include all transaction history going back to FY2024.

Spending by State

CFDA program 93.838 (Lung Diseases Research) federal funding broken down by state, sorted by total obligated amount.
StateFundingAwards
North Carolina$75.6M1
Massachusetts$64.2M1
Indiana$12.2M1
New York$5.6M1
Maryland$3.7M1

Top Recipients

Top recipients of CFDA program 93.838 (Lung Diseases Research) federal funding, with total obligated amounts and award counts.
RecipientTotalAwards
UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILLNC$75.6M1
THE GENERAL HOSPITAL CORPORATIONMA$64.2M1
TRUSTEES OF INDIANA UNIVERSITYIN$12.2M1
THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORKNY$5.6M1
UNIVERSITY OF MARYLAND, BALTIMOREMD$3.7M1

Agencies Administering This Program